Tumour diploidy and survival in breast cancer patients with BRCA2 mutations

Breast Cancer Research and Treatment

Volumn 140, Issue 2, 2013, Pages 375-384

  Tryggvadottir, Laufey ^a,b   Olafsdottir, Elinborg J ^a   Olafsdottir, Gudridur H ^a   Sigurdsson, Helgi ^b,c   Johannsson, Oskar T ^b,c   Bjorgvinsson, Einar ^c   Alexiusdottir, Kristin ^a,c   Stefansson, Olafur A ^b   Agnarsson, Bjarni A ^b,c   Narod, Steven A ^d   Eyfjord, Jorunn E ^b   Jonasson, Jon G ^a,b,c  

^a ICELANDIC CANCER REGISTRY   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRCA2 mutation; Breast cancer; Ploidy; Prognostic factors; Survival

Indexed keywords

BRCA2 PROTEIN; ESTROGEN RECEPTOR; BRCA2 PROTEIN, HUMAN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BRCA2 GENE; BREAST CANCER; CANCER CELL; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SIZE; CANCER SURVIVAL; CELL CYCLE S PHASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIPLOIDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE MUTATION; GENETIC LINKAGE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; ICELAND; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MITOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; BREAST TUMOR; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; PROGNOSIS; SURVIVAL;

ADULT; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; DIPLOIDY; FEMALE; HUMANS; MIDDLE AGED; MUTATION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84881475548     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2637-4     Document Type: Article

References (25)

1. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789-792
2. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Goldgar DE (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12(3):333-337
3. Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjord JE (2006) Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst 98(2):116-122
4. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjord JE (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60(5):1079-1084
5. Goodwin PJ, Phillips KA, West DW, Ennis M, Hopper JL, John EM, O'Malley FP, Milne RL, Andrulis IL, Friedlander ML, Southey MC, Apicella C, Giles GG, Longacre TA (2012) Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study. J Clin Oncol 30(1):19-26. doi: 10.1200/JCO.2010.33.0068
6. Bordeleau L, Panchal S, Goodwin P (2010) Prognosis of BRCA-associated breast cancer: a summary of evidence. Breast Cancer Res Treat 119(1):13-24
7. Lee EH, Park SK, Park B, Kim SW, Lee MH, Ahn SH, Son BH, Yoo KY, Kang D, Group KR, Korean Breast Cancer S (2010) Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis. Breast Cancer Res Treat 122(1):11-25
8. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396(6712):643-649
9. Weaver BA, Cleveland DW (2006) Does aneuploidy cause cancer? Curr Opin Cell Biol 18(6):658-667. doi: 10.1016/j.ceb.2006.10.002
10. Rajagopalan H, Lengauer C (2004) Aneuploidy and cancer. Nature 432(7015):338-341. doi: 10.1038/nature03099
11. Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171-182
12. Gudmundsdottir K, Ashworth A (2006) The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25(43):5864-5874
13. Gretarsdottir S, Thorlacius S, Valgardsdottir R, Gudlaugsdottir S, Sigurdsson S, Steinarsdottir M, Jonasson JG, Anamthawat-Jonsson K, Eyfjord JE (1998) BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res 58(5):859-862
14. Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, Valgeirsdottir S, Eyfjord JE (2009) Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes. Breast Cancer Res 11(4):R47
15. Stefansson OA, Jonasson JG, Olafsdottir K, Bjarnason H, Johannsson OTh, Bodvarsdottir SK, Valgeirsdottir S, Eyfjord JE (2011) Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression. Breast Cancer Res 13(5):R95. doi: 10.1186/bcr3020
16. Sigurdardottir LG, Jonasson JG, Stefansdottir S, Jonsdottir A, Olafsdottir GH, Olafsdottir EJ, Tryggvadottir L (2012) Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness. Acta Oncol 51(7):880-889. doi: 10.3109/0284186X.2012.698751
17. Brekelmans CT, Tilanus-Linthorst MM, Seynaeve C, vd Ouweland A, Menke-Pluymers MB, Bartels CC, Kriege M, van Geel AN, Burger CW, Eggermont AM, Meijers-Heijboer H, Klijn JG (2007) Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer 43(5):867-876. doi: 10.1016/j.ejca.2006.12.009
18. Agnarsson BA, Jonasson JG, Bjornsdottir IB, Barkardottir RB, Egilsson V, Sigurdsson H (1998) Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat 47(2):121-127
19. Jonasson JG, Hrafnkelsson J (1994) Nuclear DNA analysis and prognosis in carcinoma of the thyroid gland. A nationwide study in Iceland on carcinomas diagnosed 1955-1990. Virchows Archiv 425(4):349-355
20. Ross JS, Linette GP, Stec J, Ross MS, Anwar S, Boguniewicz A (2003) DNA ploidy and cell cycle analysis in breast cancer. Am J Clin Pathol 120:S72-S84
21. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, Esposito D, Alexander J, Troge J, Grubor V, Yoon S, Wigler M, Ye K, Borresen-Dale AL, Naume B, Schlicting E, Norton L, Hagerstrom T, Skoog L, Auer G, Maner S, Lundin P, Zetterberg A (2006) Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res 16(12):1465-1479
22. Venkitaraman AR (2009) Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol 4:461-487. doi: 10.1146/annurev.pathol.3.121806.151422
23. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C (1999) Genetic instability and Darwinian selection in tumours. Trends Cell Biol 9(12):M57-M60 S0962-8924(99)01661-X
24. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW (2007) Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11(1):25-36
25. Birkbak NJ, Eklund AC, Li Q, McClelland SE, Endesfelder D, Tan P, Tan IB, Richardson AL, Szallasi Z, Swanton C (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res 71(10):3447-3452. doi: 10.1158/0008-5472.CAN-10-3667